Fedenia Advisers’s Gilead Sciences GILD Stock Holding History

Fedenia Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.9K	Buy	+427	New	+$56.3K	0.01%	212

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Fedenia Advisers's GILD Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Gilead Sciences (GILD) in Q2 2026: 427 shares worth $53.9K. The stake represents 0.01% of the portfolio and ranks #212 among its holdings.

690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Fedenia Advisers held 427 shares of Gilead Sciences worth $53.9K as of Q2 2026.
Gilead Sciences was a new Fedenia Advisers position in Q2 2026.
Gilead Sciences made up 0.01% of Fedenia Advisers's portfolio in Q2 2026, its #212 holding.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.